Your COVID-19 immunity could last 'possibly a lifetime'
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
Two new studies suggest COVID-19 immunity following infection could last a year, or "possibly a lifetime, improving over time especially following vaccination" The New York Times reported on Wednesday, hopefully allaying "lingering fears that protection against the virus will be short-lived."
When taken together, the studies suggest most (but not all) vaccinated individuals who were previously infected with COVID-19 "will not need boosters," wrote the Times. Those who were vaccinated without having previously contracted the virus will likely need the extra dose. Experts expect immunity in these individuals to "play out very differently," as "immune memory" may look different following vaccination compared to natural infection.
"The papers are consistent with the growing body of literature that suggests that immunity elicited by infection and vaccination for SARS-CoV-2 appears to be long-lived," said Scott Hensley, an immunologist not involved in the studies. Dr. Michel Nussenzweig, a researcher for one of the studies, added he expects antibodies in those who were previously infected and later vaccinated to "last for a long time."
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Results, however, also underscore the idea that previous infection is not enough to protect individuals long-term on its own — even those who have recovered should be vaccinated, wrote the Times. Read more at The New York Times.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
One great cookbook: Joshua McFadden’s ‘Six Seasons of Pasta’the week recommends The pasta you know and love. But ever so much better.
-
Scientists are worried about amoebasUnder the radar Small and very mighty
-
Buddhist monks’ US walk for peaceUnder the Radar Crowds have turned out on the roads from California to Washington and ‘millions are finding hope in their journey’
-
A Nipah virus outbreak in India has brought back Covid-era surveillanceUnder the radar The disease can spread through animals and humans
-
Trump HHS slashes advised child vaccinationsSpeed Read In a widely condemned move, the CDC will now recommend that children get vaccinated against 11 communicable diseases, not 17
-
Covid-19 mRNA vaccines could help fight cancerUnder the radar They boost the immune system
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
